Friday, 24 Jan 2020

You are here

Kevin Winthrop, MD: H. zoster and tofacitinib: the risk of concomitant nonbiologic therapy

Dr. Kevin Winthrop, associate professor of infectious diseases at Oregon Health & Sciences University in Portland, Oregon, discusses abstract 559.

Add new comment

Want to talk about this video? Comment here to lead the discussion.
MORE VIDEOS

QD Video - Evaluation of Takayasu...

10 Jan 2019

Dr. Ben Nowell at EULAR 2018 - Barriers...

14 Jun 2018

RheumNow Live Preview with Dr. Paul...

23 Apr 2019

Dr. Phil Aleksiejuk: Drug-Induced ANCA...

09 Feb 2018

The RWCS - RheumNow Week in Review - 9...

09 Feb 2018

RheumNow Week in Review – Gout and...

14 Sep 2018

Dr. Jack Cush: Pregnancy Infections...

15 Nov 2016

Dr. Cush: Rheumatology Roundup

24 Oct 2018

Vasculitis Pearls: Dr. Kathryn Dao

20 Nov 2019

Dr. Rachel Tate: Early Intervention for...

21 Oct 2018

Dr. Jonathan Kay - Biosimilars at EULAR

11 Jul 2016

Dr. Philip Robinson at EULAR 2018 on...

20 Jun 2018